Greater Toronto Area, Canada
- Expertise in economic evaluation (e.g., Markov, Semi-Markov, and Partitioned Survival Analysis CEA/CUA, BIA), causal inference (e.g., DID, ATE, ATET, POM), quantitative data analysis (e.g., survival analysis, mediation/moderation analysis), and evidence synthesis (Frequentist/Bayesian) - Experienced developer of interactive visual analytics models using R Shiny, Power BI, and Tableau
- Lead the development and execution of RWE and HEOR strategies to demonstrate product value and support reimbursement, pricing, and policy decisions. - Prepare and adapt reimbursement submissions and economic models for CDA/INESSS payers, aligning with national guidelines and leveraging global value dossiers and tools. - Design, manage, and deliver RWE/HEOR studies, including protocol development, data analysis, and dissemination of findings through reports, publications, and presentations. - Collaborate cross-functionally with internal teams and external stakeholders (e.g., KOLs, payers, researchers, registries, CROs) to advance evidence generation and support market access objectives. - Ensure project excellence by managing timelines, budgets, data quality, and regulatory compliance, while maintaining awareness of evolving Canadian healthcare trends and methodologies.
- Developed a Markov model to assess the cost-effectiveness of a multi-layer silicone prophylactic dressing compared to standard care in prevention of hospital-acquired pressure injuries in non-ICU, surgical and medical settings. - Calculated costs and quality-adjusted life-years (QALYs) using individual patient data (IPD) and regression-based models using multi-attribute utility instruments such as HUI, EQ-5D-3L, EQ-5D-5L, SF-36, SF-36v2, and SF-6D, SF-6Dv2. - Developed a decision tree to evaluate the cost-utility and value of information analysis to assess the value of a larger research alongside a randomized controlled trial (individual patient data) of a technology-enhanced group rehabilitation compared to routine care in public hospitals. - Conducted, evaluated, and validated two Network meta-analyses (Bayesian and frequentist) in the industry submissions to the Agency for Care Effectiveness (ACE, serves as Singapore's national health technology assessment (HTA) and clinical guidance agency) Singapore. - Critically evaluated industry submissions to Pharmaceutical Benefits Advisory Committee (PBAC, an independent expert panel advises the Health Minister on drug funding and pricing for Australia's national pharmaceutical insurance program, the Pharmaceutical Benefits Scheme (PBS).) in oncology and rare diseases. - Co-appraised medical submissions to Medical Services Advisory Committee (MSAC, an independent body established by Australia's Health Minister to evaluate new medical services for potential public funding.) - Co-develop NHMRC and MRFF grants in rehabilitation research. - Conduct workshops on "Time-to-event (survival) analysis" and "How to increase collaborative productivity using online tools."
- Designed and implemented advanced Quality Improvement (QI) interactive visual analytics models from real-world data (RWD) using Electronic Health Records (EHR) for health care services in Spinal Cord Injury (SCI) rehabilitation, utilizing Power BI/R Shiny to enhance data-driven decision-making processes. - Developed interactive R Shiny dashboards to analyze Community Participation data, incorporating patient-reported outcomes (e.g., MSES, RNLI) for tailored report generation. - Demonstrated expertise in quantitative analysis (e.g., survival analysis, cluster/component/factor analyses, predictive modelling) - Collaboratively authored a comprehensive, step-by-step guide for conducting qualitative evidence synthesis in rehabilitation research. - Co-instructed an 'Introduction to Statistics in Health and Medical Sciences using R' course, effectively sharing knowledge and fostering skill development among participants. - Led instruction for the 'Introduction to Meta-Analysis in R' course, empowering students to effectively analyze and synthesize research data. - Developed and maintained robust databases for longitudinal rehabilitation research studies across Canada, ensuring data accuracy and accessibility for researchers. - Delivered a well-received oral presentation at the American Spinal Injury Association (ASIA) conference in 2022, showcasing research findings and fostering collaboration among professionals. - Co-conducted a hands-on workshop at the ASIA conference in 2022, providing valuable training and insights to attendees. - Presented research findings at the International Spinal Cord Society (ISCoS) conference in 2022, contributing to the ongoing advancement of spinal cord injury care and research. - Conducted longitudinal data analysis of pain management techniques and life satisfaction among individuals with lived Spinal Cord Injury/Disease (SCI/D) experience, providing valuable insights for improving patient care and quality of life.
- Collaborated in the development of seven grant applications for prominent organizations such as CIHR, CHRP, NSERC, PSI, and WCBM. - Performed analysis of quality of life impacts of a novel health technology, providing valuable data for decision-making in health care resource allocation. - Conducted a comprehensive scoping review in partnership with Cochrane Rehabilitation, contributing to the knowledge base in the field of rehabilitation medicine. - Conducted network meta-analysis, synthesizing evidence of nociceptive flexion reflex threshold in multiple chronic pain conditions.
- Conducted a systematic review on CEA models in diabetes and risk factors contributing to cardiovascular diseases - Conducted three workshops on CEA in TreeAge and statistical modelling using Stata and SPSS - Collaborated in the development of three articles and international conferences - Provided consultation for designing a randomized controlled trial for Sanofi Malaysia